Ken Fisher Lexicon Pharmaceuticals, Inc. Transaction History

Fisher Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 12, 2023	BUY	$2.15 - $3.49 $1.13 Million - $1.83 Million	523,394 New	523,394 $1.2 Million
Q2 2023 Aug 08, 2023	SELL	$2.15 - $3.49 $423,225 - $687,003	-196,849 Reduced 27.33%	523,394 $1.2 Million
Q1 2023 Dec 12, 2023	BUY	$1.99 - $2.68 $1.29 Million - $1.74 Million	649,726 New	649,726 $1.58 Million
Q4 2022 Feb 03, 2023	BUY	$1.8 - $2.56 $206,487 - $293,670	114,715 Added 18.94%	720,243 $1.38 Million
Q2 2022 Aug 09, 2022	BUY	$1.31 - $2.69 $310,907 - $638,428	237,334 Added 64.46%	605,528 $1.13 Million
Q1 2022 May 05, 2022	BUY	$1.95 - $3.89 $384,976 - $767,979	197,424 Added 115.61%	368,194 $770,000
Q4 2021 Feb 02, 2022	BUY	$3.81 - $6.16 $650,633 - $1.05 Million	170,770 New	170,770 $673,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $185M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.